PARP1 and head and neck squamous cell carcinoma: Having established that the present in vitro-EJ assay can detect the switch to Alt-EJ and hence the associated PARP inhibitor (PARPi) radiosensitization, we used it to detect the pathway switch in HNSCC cells.